| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.05 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |